Barclays Downgrades Illumina (NASDAQ:ILMN) to Underweight
Illumina (NASDAQ:ILMN – Get Free Report) was downgraded by investment analysts at Barclays from an “equal weight” rating to ...
Hosted on MSN4d
Barclays Downgrades Illumina (ILMN)
Fintel reports that on February 10, 2025, Barclays downgraded their outlook for Illumina (NasdaqGS:ILMN) from Equal-Weight to ...
Why Illumina Stock Got Mashed on Monday
On Monday, for the second time in as many business days, Illumina ( ILMN -4.11%) stock took it on the chin because of an analyst recommendation downgrade. The biotech's shares closed the day almost 6% ...
StockStory.org on MSN4d
Why Illumina (ILMN) Stock Is Trading Lower Today
What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 7.5% in the morning session after Barclays downgraded ...
6ILMN : Decoding Illumina's Options Activity: What's the...
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...
Morgan Stanley Remains a Hold on Illumina (ILMN)
Morgan Stanley analyst Tejas Savant maintained a Hold rating on Illumina (ILMN – Research Report) today and set a price target of $136.00. The ...
Illumina price target raised to $190 from $185 at Piper Sandler
Piper Sandler analyst David Westenberg raised the firm’s price target on Illumina (ILMN) to $190 from $185 following quarterly results. The ...
Illumina: Regulatory Risk In China And Weaker Sales Rebound Mask A Solid Rebound Of Its Profitability
The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...
Why Illumina (ILMN) Stock Is Falling Today
Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning session after the company reported fourth-quarter ...